References
- Ascher-Svanum, H., Nyhuis, A. W., Stauffer, V., Kinon, B. J., Faries, D. E., Phillips, G. A., Schuh, K., Awad, A. G., Keefe, R., & Naber, D. (2010). Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives. Current Medical Research and Opinion, 26(10), 2403–2410. https://doi.org/https://doi.org/10.1185/03007995.2010.515900
- Bjornestad, J., Davidson, L., Joa, I., Larsen, T. K., Hegelstad, W. T. V., Langeveld, J., Veseth, M., Melle, I., Johannessen, J. O., & Bronnick, K. (2017). Antipsychotic treatment: Experiences of fully recovered service users. Journal of Mental Health, 26(3), 264–270. https://doi.org/https://doi.org/10.1080/09638237.2017.1294735
- Bjornestad, J., Lavik, K. O., Davidson, L., Hjeltnes, A., Moltu, C., & Veseth, M. (2020). Antipsychotic treatment–A systematic literature review and meta-analysis of qualitative studies. Journal of Mental Health, 29(5), 513–523. https://doi.org/https://doi.org/10.1080/09638237.2019.1581352
- Boath, E., Bradley, E., & Henshaw, C. (2004). Women's views of antidepressants in the treatment of postnatal depression. Journal of Psychosomatic Obstetrics and Gynaecology, 25(3–4), 221–233. https://doi.org/https://doi.org/10.1080/01674820400017889
- Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/https://doi.org/10.1191/1478088706qp063oa
- Britten, N., Riley, R., & Morgan, M. (2010). Resisting psychotropic medicines: A synthesis of qualitative studies of medicine-taking. Advances in Psychiatric Treatment, 16(3), 207–218. https://doi.org/https://doi.org/10.1192/apt.bp.107.005165
- Bülow, P., Andersson, G., Denhov, A., & Topor, A. (2016). Experience of psychotropic medication–An interview study of persons with psychosis. Issues in Mental Health Nursing, 37(11), 820–828. https://doi.org/https://doi.org/10.1080/01612840.2016.1224283
- Cappleman, R., Smith, I., & Lobban, F. (2015). Managing bipolar moods without medication: A qualitative investigation. Journal of Affective Disorders, 174(15), 241–249. https://doi.org/https://doi.org/10.1016/j.jad.2014.11.055
- Chakrabarti, S. (2014). What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World Journal of Psychiatry, 4(2), 30–36. https://doi.org/https://doi.org/10.5498/wjp.v4.i2.30
- Chambers, M., McAndrew, S., Nolan, F., Thomas, B., Watts, P., & Kantaris, X. (2017). Service user involvement in the coproduction of a mental health nursing metric: The Therapeutic Engagement Questionnaire. Health Expectations, 20(5), 871–877. https://doi.org/https://doi.org/10.1111/hex.12526
- Clark, M. (2015). Co-production in mental health care. Mental Health Review Journal, 20(4), 213–219. http://eprints.lse.ac.uk/64331/ https://doi.org/https://doi.org/10.1108/MHRJ-10-2015-0030
- Cooper, R. E., Hanratty, É., Morant, N., & Moncrieff, J. (2019). Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation. PLoS One, 14(6), e0218711. https://doi.org/https://doi.org/10.1371/journal.pone.0218711
- Department of Health. (2020, June 17). Sharing the vision: A mental health policy for everyone. https://www.gov.ie/en/publication/2e46f-sharing-the-vision-a-mental-health-policy-for-everyone/
- Flore, J., Kokanović, R., Callard, F., Broom, A., & Duff, C. (2019). Unravelling subjectivity, embodied experience and (taking) psychotropic medication. Social Science & Medicine, 230, 66–73. https://doi.org/https://doi.org/10.1016/j.socscimed.2019.04.004
- Fu, S., Czajkowski, N., & Torgalsbøen, A. K. (2019). Cognitive, work and social outcomes in fully recovered first-episode schizophrenia: On and off antipsychotic medication. Psychiatry Interpersonal Psychiatry, 82(1), 42–56. https://doi.org/https://doi.org/10.1080/00332747.2018.1550735
- Gale, C., Baldwin, L., Staples, V., Montague, J., & Waldram, D. (2012). An exploration of the experience of mental health service users when they decide they would like to change or withdraw from prescribed medications. Journal of Psychiatric and Mental Health Nursing, 19(10), 853–859. https://doi.org/https://doi.org/10.1111/j.1365-2850.2011.01860.x
- Givens, J. L., Datto, C. J., Ruckdeschel, K., Knott, K., Zubritsky, C., Oslin, D. W., Nyshadham, S., Vanguri, P., & Barg, F. K. (2006). Older patients’ aversion to antidepressants: A qualitative study. Journal of General Internal Medicine, 21(2), 146–151. https://doi.org/https://doi.org/10.1111/j.1525-1497.2005.00296.x
- Harris, K., Brooks, H., Lythgoe, G., Bee, P., Lovell, K., & Drake, R. J. (2017). Exploring service users’, carers’ and professionals’ perspectives and experiences of current antipsychotic prescribing: A qualitative study. Chronic Illness, 13(4), 275–287. https://doi.org/https://doi.org/10.1177/1742395317694223
- Healy, D. (2016). Psychiatric drugs explained. Elsevier Health Sciences.
- Higgins, A., Doyle, L., Downes, C., Morrissey, J., Costello, P., Brennan, M., & Nash, M. (2016). There is more to risk and safety planning than dramatic risks: Mental health nurses’ risk assessment and safety-management practice. International Journal of Mental Health Nursing, 25(2), 159–170. https://doi.org/https://doi.org/10.1111/inm.12180
- Health Service Executive. (2017). National framework for recovery in Mental Health 2018–2020. HSE.
- Katz, S., Goldblatt, H., Hasson-Ohayon, I., & Roe, D. (2019). Retrospective accounts of the process of using and discontinuing psychiatric medication. Qualitative Health Research, 29(2), 198–210. https://doi.org/https://doi.org/10.1177/1049732318793418
- Kreyenbuhl, J., Leith, J., Medoff, D. R., Fang, L., Dickerson, F. B., Brown, C. H., Goldberg, R., Potts, W., & Dixon, L. B. (2011). A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness. Psychiatry Research, 188(1), 109–114. https://doi.org/https://doi.org/10.1016/j.psychres.2011.03.013
- Le Boutillier, C., Leamy, M., Bird, V. J., Davidson, L., Williams, J., & Slade, M. (2011). What does recovery mean in practice? A qualitative analysis of international recovery-oriented practice guidance. Psychiatric Services, 62(12), 1470–1476. https://doi.org/https://doi.org/10.1176/appi.ps.001312011
- Le Geyt, G., Awenat, Y., Tai, S., & Haddock, G. (2017). Personal accounts of discontinuing neuroleptic medication for psychosis. Qualitative Health Research, 27(4), 559–572. https://doi.org/https://doi.org/10.1177/1049732316634047
- Moisan, J., & Grégoire, J. P. (2010). Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis. Clinical Therapeutics, 32, S21–S31. https://doi.org/https://doi.org/10.1016/j.clinthera.2010.01.003
- Morant, N., Azam, K., Johnson, S., & Moncrieff, J. (2018). The least worst option: User experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. Journal of Mental Health, 27(4), 322–328. https://doi.org/https://doi.org/10.1080/09638237.2017.1370637
- Morant, N., Kaminskiy, E., & Ramon, S. (2016). Shared decision making for psychiatric medication management: Beyond the micro‐social. Health Expectations, 19(5), 1002–1014. https://doi.org/https://doi.org/10.1111/hex.12392
- Moritz, S., Andreou, C., Klingberg, S., Thoering, T., & Peters, M. J. (2013). Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect? Neuropharmacology, 72, 179–186. https://doi.org/https://doi.org/10.1016/j.neuropharm.2013.04.039
- Morrison, A. P., Hutton, P., Shiers, D., & Turkington, D. (2012). Antipsychotics: Is it time to introduce patient choice? The. British Journal of Psychiatry, 201(2), 83–84. https://doi.org/https://doi.org/10.1192/bjp.bp.112.112110
- National Institute for Health and Care Excellence (NICE). (2014, March 1). Psychosis and schizophrenia in adults: Prevention and management. (Clinical Guidelines No. 178). National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/cg178
- National Institute for Health and Care Excellence (NICE). (2020, February 17). Antidepressant Treatment in Adults, NICE Pathways. National Institute for Health and Care Excellence. http://pathways.nice.org.uk/pathways/depression
- Paris, J. (2010). The use and misuse of psychiatric drugs: An evidence-based critique. John Wiley & Sons.
- Ramachandraiah, C. T., Subramaniam, N., & Tancer, M. (2009). The story of antipsychotics: Past and present. Indian Journal of Psychiatry, 51(4), 324–326. https://doi.org/https://doi.org/10.4103/0019-5545.58304
- Read, J., Grigoriu, M., Gee, A., Diggle, J., & Butler, H. (2020). The positive and negative experiences of 342 antidepressant users. Community Mental Health Journal, 56(4), 744–752. https://doi.org/https://doi.org/10.1007/s10597-019-00535-0
- Roe, D., Goldblatt, H., Baloush-Klienman, V., Swarbrick, M., & Davidson, L. (2009). Why and how people decide to stop taking prescribed psychiatric medication: Exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33(1), 38–46. https://doi.org/https://doi.org/10.2975/33.1.2009.38.46
- Salomon, C., & Hamilton, B. (2013). All roads lead to medication? Qualitative responses from an australian first person survey of antipsychotic discontinuation. Psychiatric Rehabilitation Journal, 36(3), 160–165. https://doi.org/https://doi.org/10.1037/prj0000001
- Salomon, C., Hamilton, B., & Elsom, S. (2014). Experiencing antipsychotic discontinuation: Results from a survey of Australian consumers. Journal of Psychiatric and Mental Health Nursing, 21(10), 917–923. https://doi.org/https://doi.org/10.1111/jpm.12178
- Sapra, M., Weiden, P. J., Schooler, N. R., Sunakawa-McMillan, A., Uzenoff, S., & Burkholder, P. (2014). Reasons for adherence and nonadherence: A pilot study comparing first-and multi-episode schizophrenia patients. Clinical Schizophrenia & Related Psychoses, 7(4), 199–206. https://doi.org/https://doi.org/10.3371/CSRP.SAWE.020813
- Shepherd, G., Boardman, J., & Slade, M. (2008). Making recovery a reality. Sainsbury Centre for Mental Health.
- Slade, M., Amering, M., & Oades, L. (2008). Recovery: An international perspective. Epidemiologia e Psichiatria Sociale, 17(2), 128–137. https://doi.org/https://doi.org/10.1017/S1121189X00002827
- Sparks, J. A. (2016). White paper: Efficacy of psychiatric drugs. Ethical Human Psychology and Psychiatry, 18(1), 20–28. https://doi.org/https://doi.org/10.1891/1559-4343.18.1.20
- Steingard, S, (2019). Clinical implications of the drug-centered approach. In S. Steingard (Ed.), Critical psychiatry: Controversies and clinical implications (pp. 113–135). Springer.
- Teferra, S., Hanlon, C., Beyero, T., Jacobsson, L., & Shibre, T. (2013). Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: A qualitative study of patients, caregivers and health workers. BMC Psychiatry, 13(1), 1–9. https://doi.org/https://doi.org/10.1186/1471-244X-13-168
- Thomas, J., & Harden, A. (2008). Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Medical Research Methodology, 8(1), 1–10. https://doi.org/https://doi.org/10.1186/1471-2288-8-45
- Thompson, J., Stansfeld, J. L., Cooper, R. E., Morant, N., Crellin, N. E., & Moncrieff, J. (2020). Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: A systematic review and thematic synthesis of qualitative data. Social Psychiatry and Psychiatric Epidemiology, 55(2), 151–164. https://doi.org/https://doi.org/10.1007/s00127-019-01819-2
- Tranulis, C., Goff, D., Henderson, D. C., & Freudenreich, O. (2011). Becoming adherent to antipsychotics: A qualitative study of treatment-experienced schizophrenia patients. Psychiatric Services, 62(8), 888–892. https://doi.org/https://doi.org/10.1176/ps.62.8.pss6208_0888
- Verdoux, H., Pambrun, E., Tournier, M., Bezin, J., & Pariente, A. (2017). Risk of discontinuation of antipsychotic long‐acting injections vs. oral antipsychotics in real‐life prescribing practice: A community‐based study. Acta Psychiatrica Scandinavica, 135(5), 429–438. https://doi.org/https://doi.org/10.1111/acps.12722
- Walter, H. (2013). The third wave of biological psychiatry. Frontiers in Psychology, 4 (582), 1–8. https://doi.org/https://doi.org/10.3389/fpsyg.2013.00582
- Wunderink, L. (2019). Personalizing antipsychotic treatment: Evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders. Therapeutic Advances in Psychopharmacology, 9, 204512531983656. https://doi.org/https://doi.org/10.1177/2045125319836566
- Zarea, K., Fereidooni-Moghadam, M., & Hakim, A. (2016). Adherence to medication regimen in patients with severe and chronic psychiatric disorders: A qualitative study. Issues in Mental Health Nursing, 37(11), 868–874. https://doi.org/https://doi.org/10.1080/01612840.2016.1239147